Skip to content

Public FDA record

Z-1523-2008: CryoValve, Aortic Valve & Conduit

Recall record Z-1523-2008 for CryoLife, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1523-2008
Company in FDA record
CryoLife, Inc.
FDA classification date
Sep 1, 2008
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Unknown — no matched enforcement classification

Reason stated in the source

Tissues taken from a donor whose blood culture was found positive for Serratia marcescens, was distributed.

Source facts

Action
Hospitals were notified by letter on 3/24/2008. They were advised not to implanted the tissue and if implanted, they do not recommend explant unless medically necessary. A self addressed, stamped post card was included to confirm receipt of the notification. Serial number 8895391 was reported implanted. Serial number 8895131 was returned to CryoLife for destruction.
Initiated
2008-03-26
Root cause
Material/Component Contamination
Terminated
2010-01-12
Distribution
Hospitals in DE, TN
Recall number
Z-1523-2008
Recall status
Terminated
CDRH record ID
69657
FDA classified
2008-09-01
Recall event number
47517

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗